RM Lowenthal

628 total citations
20 papers, 451 citations indexed

About

RM Lowenthal is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, RM Lowenthal has authored 20 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in RM Lowenthal's work include Acute Myeloid Leukemia Research (5 papers), Neutropenia and Cancer Infections (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). RM Lowenthal is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Neutropenia and Cancer Infections (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). RM Lowenthal collaborates with scholars based in Australia, United Kingdom and United States. RM Lowenthal's co-authors include Ralph Cobcroft, JP Matthews, H. Kronenberg, Dong Ma, D. Joshua, Anthony J. Dodds, D. Todd, Richard Kefford, Coates As and Michael Adena and has published in prestigious journals such as The Lancet, Blood and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

RM Lowenthal

20 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RM Lowenthal Australia 9 254 184 166 91 74 20 451
Marek J. Bozdech United States 10 262 1.0× 104 0.6× 99 0.6× 83 0.9× 45 0.6× 18 390
A.K. Burnett United Kingdom 11 327 1.3× 127 0.7× 95 0.6× 101 1.1× 41 0.6× 22 449
Andreas Grüneisen Germany 9 432 1.7× 83 0.5× 214 1.3× 150 1.6× 45 0.6× 11 586
C Stainer United Kingdom 11 282 1.1× 122 0.7× 46 0.3× 49 0.5× 90 1.2× 12 384
Spurr Cl United States 8 132 0.5× 113 0.6× 74 0.4× 111 1.2× 31 0.4× 20 326
Shaoyan Hu China 11 128 0.5× 76 0.4× 142 0.9× 67 0.7× 46 0.6× 33 376
Fabiana Ostronoff United States 11 467 1.8× 97 0.5× 154 0.9× 181 2.0× 53 0.7× 27 569
S.J. Proctor United Kingdom 10 124 0.5× 63 0.3× 72 0.4× 53 0.6× 102 1.4× 22 348
April Sorrell United States 9 314 1.2× 90 0.5× 114 0.7× 201 2.2× 32 0.4× 18 498
Mauro Turrini Italy 12 160 0.6× 131 0.7× 135 0.8× 35 0.4× 33 0.4× 26 400

Countries citing papers authored by RM Lowenthal

Since Specialization
Citations

This map shows the geographic impact of RM Lowenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RM Lowenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RM Lowenthal more than expected).

Fields of papers citing papers by RM Lowenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RM Lowenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RM Lowenthal. The network helps show where RM Lowenthal may publish in the future.

Co-authorship network of co-authors of RM Lowenthal

This figure shows the co-authorship network connecting the top 25 collaborators of RM Lowenthal. A scholar is included among the top collaborators of RM Lowenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RM Lowenthal. RM Lowenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowenthal, RM, et al.. (2007). A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting. Cytotherapy. 9(2). 158–164. 3 indexed citations
2.
Lowenthal, RM. (2005). Cancer impact on Indigenous communities: overview. eCite Digital Repository (University of Tasmania). 29. 5. 1 indexed citations
3.
Bradstock, KF, et al.. (2001). Intensive chemotherapy in induction and consolidation for De Novo adult acute myeloid leukemia using sequential courses of high dose cytarabine, idarubicin, and etoposide: a randomized trial of the Australian leukaemia and lymphoma group (ALLG).. eCite Digital Repository (University of Tasmania). 2 indexed citations
4.
Snowden, John A., John J. Moore, Paul Cannell, et al.. (2001). Autologous stem cell transplantation in rheumatoid arthritis. eCite Digital Repository (University of Tasmania). 3 indexed citations
5.
Lowenthal, RM, et al.. (2001). Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation. Bone Marrow Transplantation. 28(10). 929–933. 11 indexed citations
6.
Lowenthal, RM, et al.. (2000). Cold sweat case report. The Lancet. 356. 2064. 2 indexed citations
7.
Lowenthal, RM, et al.. (2000). Cold sweats. The Lancet. 356(9247). 2064–2064. 3 indexed citations
8.
Bradstock, KF, et al.. (1999). Effects of lenograstim (glycosylated huG-CSF) after high dose cytarabine-based induction chemotherapy for adult acute myeloid leukemia (AML). eCite Digital Repository (University of Tasmania). 2 indexed citations
9.
Lowenthal, RM, JP Matthews, Ralph Cobcroft, et al.. (1999). A Phase I/II Study of Intensive Dose Escalation of Cytarabine in Combination with Idarubicin and Etoposide in Induction and Consolidation Treatment of Adult Acute Myeloid Leukemia. Leukemia & lymphoma. 34(5-6). 501–510. 6 indexed citations
10.
Lowenthal, RM, et al.. (1997). Review article. Myelodysplastic syndromes. International Journal of Hematology. 65. 319–338. 20 indexed citations
11.
Lowenthal, RM, et al.. (1996). Chemotherapy at home. eCite Digital Repository (University of Tasmania). 1 indexed citations
12.
Adena, Michael, et al.. (1993). Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial.. PubMed. 3(2). 133–8. 87 indexed citations
13.
Lowenthal, RM & Giorgio Lambertenghi‐Deliliers. (1992). Oral idarubicin as treatment for advanced myelodysplastic syndrome.. PubMed. 76(5). 398–401. 8 indexed citations
14.
Lowenthal, RM, D. Joshua, JP Matthews, et al.. (1990). Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood. 75(1). 27–32. 176 indexed citations
15.
Lowenthal, RM, D. Joshua, JP Matthews, et al.. (1990). Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood. 75(1). 27–32. 8 indexed citations
16.
Lowenthal, RM, et al.. (1989). Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.. Journal of Neurology Neurosurgery & Psychiatry. 52(5). 566–574. 29 indexed citations
19.
Lowenthal, RM, et al.. (1987). Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients.. PubMed. 71(12). 1279–81. 24 indexed citations
20.
Lowenthal, RM, et al.. (1975). Intensive leukapheresis as initial therapy for chronic granulocytic leukemia. Blood. 46(6). 835–844. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026